1. Acute effect of add‐on therapy with tofogliflozin, a sodium glucose co‐transporter 2 inhibitor, on 24‐hours glucose profile and glycaemic variability evaluated by continuous glucose monitoring in patients with type 2 diabetes receiving dipeptidyl peptidase‐4 inhibitors. Issue 11 (19th August 2021) Authors: Iijima, Toshie; Hosonuma, Soichiro; Kurai, Hidetaka; Kajitani, Hayato; Sakurai, Shintaro; Tomaru, Takuya; Jojima, Teruo; Usui, Isao; Aso, Yoshimasa Journal: International journal of clinical practice Issue: Volume 75:Issue 11(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗